Condition: Cervical Cancer · Cervical Dysplasia · Human Papillomavirus Infection · Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic
The trial will evaluate whether self-sampling and human papillomavirus (HPV) testing may increase cervical cancer screening attendance among under-screened women in Czech Republic. Different ways of offering self-sampling device will be evaluated.
This description comes directly from the study's public registry record.
Marian Hajduch, MD, PhD. · +420 585 632 083 · marian.hajduch@upol.cz
Vladimira Koudelakova, MSc, Ph.D. · +420 585 632 089 · vladimira.koudelakova@upol.cz
Always discuss trial participation with your own doctor first.
| University Hospital Olomouc | Olomouc, Czechia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04226313